To evaluate the effects of nitric oxide in ovarian cancer cells, the level of nitric oxide was measured by detecting nitrosating species in the media of the OVCAR3 and SKOV3 cells after treatment with NOS inhibitor L-NAME or NO donor DETA-NONOate by Griess assay. Here, NOS2 is linked to ovarian carcinoma.